About Editorial team of BIPNs

Main team of content of bipns.com. Any type of content should be approved by us.
2 01, 2026

Best NMN Supplement 2026 Report: GenuinePurity Liposomal NMN Cited in NAD+ Longevity Industry Analysis

By |2026-01-02T00:59:35+02:00January 2, 2026|Dietary Supplements News, News|0 Comments


Leading Edge Health’s GenuinePurity Liposomal NMN Evaluated in Criteria-Based NAD+ Quality Standards Analysis Examining Purity Verification, Liposomal Absorption Technology, 250mg Dosage Research, and Cellular Health Support Framework for Adults Seeking Longevity Supplementation in 2026

SAN FRANCISCO, CA, Jan. 01, 2026 (GLOBE NEWSWIRE) — FOR IMMEDIATE RELEASE

Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before starting any new supplement regimen. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary. This article contains affiliate links. If you purchase through these links, a commission may be earned at no additional cost to you. This compensation does not influence the accuracy or integrity of the information presented.

As millions of Americans enter 2026 with resolutions focused on energy, mental clarity, and proactive wellness, the question of which NMN supplement meets quality standards that actually matter has become central to the purchasing decision.

This industry analysis examines GenuinePurity Liposomal NMN within the context of five evaluation criteria developed from published research, manufacturing standards, and consumer protection considerations. The goal is not to declare a winner, but to provide a framework for informed decision-making in a category where quality variance remains significant.

Get the latest news


delivered to your inbox

Sign up for The Manila Times newsletters

By signing up with an email address, I acknowledge that I have read and agree to the Terms of Service and Privacy Policy.

Defining “Best” Through Evaluation Criteria

The term “best” in this analysis refers to how a product aligns with objective quality markers – not subjective preference or promotional ranking. The five criteria examined include purity verification, dosage research alignment, manufacturing standards, company accountability, and authenticity documentation. This criteria-based framework allows readers to evaluate products based on factors that matter to them individually.

This analysis reviews NAD+ research context, delivery-method considerations, five evaluation criteria, how GenuinePurity aligns with those criteria, a self-assessment framework, realistic expectation context, and the company’s stated guarantee and contact details.

Part 1: Understanding the “Best NMN Supplement 2026” Search

Why People Are Searching This Phrase Right Now

The phrase “best NMN supplement 2026” reflects a specific moment in the consumer journey. Someone searching this phrase has likely already encountered NMN through advertising, a podcast mention, a friend’s recommendation, or a publication article about longevity research.

They are not asking “what is NMN?” They are asking: “I understand NMN may support cellular health. Now help me evaluate which option appears to meet quality standards and fits my priorities.”

This is a validation search. The searcher has hope but also skepticism. They have likely been disappointed by supplements before. They want information that respects their intelligence while addressing their concerns directly.

If that describes you, this analysis is designed to provide exactly that.

The New Year Context

January represents peak season for health-focused decision-making. Resolution energy is high. People are willing to invest in themselves. But they are also more cautious about wasting money on products that do not meet their expectations.

The NMN category presents particular challenges: products vary widely in sourcing transparency, formulation approach, and documentation standards. Without clear evaluation criteria, making an informed choice becomes difficult.

This analysis aims to address that challenge.

Part 2: Why NAD+ and NMN Have Captured Longevity Research Attention

The NAD+ Research Context

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme present in every living cell. Research published in peer-reviewed journals indicates NAD+ is involved in many biological processes, including cellular energy production, DNA repair, and metabolic function.

According to research published in Integrative Medicine: A Clinician’s Journal, NAD+ levels change with age. By middle age, NAD+ levels may be reduced compared to youthful levels. This change has been examined in research for its relationship to cellular energy, metabolic function, and cellular resilience.

Why NMN Emerged as a Research Focus

NMN (nicotinamide mononucleotide) is a direct precursor to NAD+. According to research, the body converts NMN into NAD+ through established biosynthetic pathways. This makes NMN supplementation a potential approach to supporting NAD+ levels.

A frequently cited paper in Nature Metabolism examined evidence of intestinal NMN uptake in animal models, contributing to understanding of how oral NMN may be absorbed.

Multiple clinical trials have examined NMN supplementation in humans. A 2022 study published in GeroScience examined NMN at various dosage levels. A 2024 meta-analysis reviewed findings across 12 clinical trials, concluding that NMN safely and effectively elevates NAD+ in humans.

Important Context: This is ingredient-level research. Individual products, including GenuinePurity Liposomal NMN, have not been independently studied as finished formulations. Research findings about NMN as an ingredient provide context but do not guarantee specific outcomes from any particular product.

Common Age-Related Concerns and NAD+ Research Context

Understanding why people search for NMN supplements requires understanding the concerns that drive their interest. The following represents research context about NAD+ and common age-related experiences – not treatment claims for any condition.

Energy and Cellular Function

NAD+ is directly involved in cellular energy production through its role in mitochondrial function. Research published in peer-reviewed journals has examined how NAD+ levels change with age. Many adults over 40 report interest in cellular health support – an interest that has contributed to growing attention on NAD+ precursor supplementation in the longevity research community.

Cognitive Function Research

The brain is one of the most energy-demanding organs, consuming approximately 20% of the body’s energy despite representing only 2% of body mass. Research has examined NAD+’s role in brain energy production and neuronal function. Studies in animal models have examined NMN administration and hippocampal function. While human research is ongoing, the mechanistic basis for NAD+’s role in brain function is established in the scientific literature.

Recovery and Physical Activity

NAD+ is involved in cellular repair processes. Research has examined NAD+ in the context of physical activity and recovery. This research context is relevant for active adults interested in cellular health support.

Metabolic Function Research

NAD+ plays a role in metabolic processes including glucose metabolism. Research has examined NAD+ supplementation in the context of metabolic health markers. This research context is relevant for adults interested in metabolic wellness.

Important Clarification: NMN supplementation is not a treatment for any medical condition. The research context above explains why people interested in cellular health have shown interest in NAD+ precursor supplementation. Individual responses vary significantly, and healthcare provider consultation is recommended before beginning any supplement regimen.

Part 3: The Absorption Question – Why Delivery Method Matters

The Bioavailability Challenge

One of the most significant discussions in NMN supplementation concerns absorption. Research indicates that absorption rates may vary between individuals and products. Digestive processes may affect NMN before absorption occurs, though the degree of this effect varies.

This has led some researchers and formulators to explore enhanced delivery mechanisms designed to support NMN through the digestive process.

Liposomal Technology Explained

Liposomes are microscopic spheres composed of phospholipids – the same material that forms cell membranes. When NMN is encapsulated within liposomes, it may be supported through the digestive process.

The liposomal structure is designed to merge with cell membranes, potentially facilitating cellular uptake. Research on liposomal delivery has been applied across pharmaceutical and nutraceutical categories.

Christopher Shade, PhD, founder of Quicksilver Scientific, noted in an interview published in Integrative Medicine: A Clinician’s Journal: “Recently it has been found that nicotinamide mononucleotide is traded cell to cell in these small vesicles that look like liposomes… so the liposome doesn’t just help the initial absorption; some of the liposomes will break down as they’re absorbed, and as a result the NMN gets into the system, but some will be intact as these little nano liposomes of NMN, and the body knows how to work with those little packages-even better than the NMN released directly into the blood.”

This research context suggests liposomal delivery may align with the body’s natural NMN transport mechanisms, providing scientific rationale for the formulation approach.

GenuinePurity utilizes liposomal encapsulation technology in its NMN formulation. Per the company, this approach addresses absorption considerations that affect the NMN supplement category broadly.

Comparative Delivery Methods

Beyond liposomal delivery, the NMN market includes sublingual formulations (designed for absorption under the tongue), enteric-coated capsules (designed to survive stomach acid), and standard capsules or powders.

Each approach has proponents. Research has shown that NMN can be absorbed orally – a 2022 study published in GeroScience demonstrated that standard NMN supplementation raises NAD+ levels in humans. Product quality and absorption efficiency vary across the NMN supplement category, depending on sourcing, formulation, and delivery method.

For those who have tried standard NMN without experiencing anticipated results, or for those prioritizing absorption optimization from the outset, liposomal delivery represents one approach to addressing absorption variability. Individual responses to any supplementation approach vary significantly.

Part 4: Five Criteria for Evaluating NMN Supplements

The term “best” requires definition. Rather than subjective ranking, the following criteria framework provides objective evaluation factors drawn from manufacturing standards, research context, and consumer protection considerations.

Criterion 1: Purity Verification

Why It Matters: NMN purity directly affects potency and potential contaminant exposure. Products with lower purity percentages may contain manufacturing byproducts or filler compounds.

Industry Context: Quality NMN products typically specify purity percentages of 95% or higher. Premium formulations often target 96%+ purity with third-party laboratory verification.

GenuinePurity Liposomal NMN: Per the company’s Certificate of Authenticity, the formulation contains 96% pure β-Nicotinamide Mononucleotide. Third-party laboratory testing verifies purity claims, with certificates available for review.

Evaluation Question: Does the NMN supplement provide verified purity documentation, or does it rely on unsubstantiated percentage claims?

Criterion 2: Dosage Research Alignment

Why It Matters: Clinical research on NMN has examined specific dosage levels. Products with dosages significantly below or above research parameters may not align with available evidence.

Research Context: Published clinical trials have examined NMN at dosages ranging from 250mg to 1000mg daily. A 2024 meta-analysis noted that benefits were observed across this range, with 250mg representing a commonly studied level that demonstrated NAD+ elevation in human participants.

GenuinePurity Liposomal NMN: Each serving contains 250mg of NMN – a dosage aligned with clinical research parameters. Per the company, the liposomal delivery is designed to address absorption considerations at this dosage level.

Evaluation Question: Does the supplement’s dosage align with published research, and does the delivery method address absorption considerations?

Criterion 3: Manufacturing Standards and Transparency

Why It Matters: Supplement manufacturing varies significantly in quality control, contamination prevention, and consistency. Products manufactured in facilities without appropriate certifications may present quality and safety questions.

Industry Standards: cGMP (Current Good Manufacturing Practice) certification indicates compliance with FDA manufacturing standards. FDA registration means facilities are subject to inspection. Third-party testing provides independent verification of product claims.

GenuinePurity Liposomal NMN: Per company documentation, the product is manufactured in cGMP-certified, FDA-registered facilities located in the USA. Each batch undergoes third-party laboratory testing. The company has operated in the natural supplement space for over 20 years under the Leading Edge Health parent organization.

Evaluation Question: Is the supplement manufactured in certified facilities with independent testing verification?

Criterion 4: Company Accountability and Consumer Protection

Why It Matters: Guarantee terms and company accessibility indicate accountability. Products backed by meaningful guarantees demonstrate confidence in outcomes. Accessible customer service indicates operational legitimacy.

Consumer Protection Standards: Quality supplements typically include satisfaction guarantees allowing returns within a reasonable timeframe. Legitimate companies provide verifiable contact information including phone support.

GenuinePurity Liposomal NMN: Per the official website, GenuinePurity offers a 97-day money-back guarantee. Customers may try the product for 90 days (two containers) and return within 97 days of delivery for a full refund (excluding shipping charges) if not satisfied. The company provides toll-free customer support at 1-866-968-6643 and international support at 1-778-770-2961.

Evaluation Question: Does the company stand behind its product with meaningful guarantee terms and accessible support?

Criterion 5: Authenticity Verification

Why It Matters: The NMN market has faced authenticity questions. Product quality and formulation accuracy vary across the supplement category. Certificate of Authenticity documentation helps verify that products contain what they claim.

Industry Context: Public reporting in 2025 discussed FDA correspondence related to NMN and dietary supplement regulatory status. This provided context for NMN products in the supplement category. However, authenticity verification remains important at the individual product level.

GenuinePurity Liposomal NMN: Per company documentation, Certificate of Authenticity is available for the product, verifying that it contains genuine β-Nicotinamide Mononucleotide at the claimed purity level. This addresses authentication considerations in the NMN supplement category.

Evaluation Question: Can the product’s NMN content be verified through certificate documentation?

Part 5: Self-Assessment Framework – Is NMN Supplementation Right for You?

Rather than universal recommendations, consider whether your individual circumstances align with the research context for NMN supplementation. This framework helps readers evaluate whether further research and healthcare provider consultation about NMN might be appropriate.

This Analysis May Be Relevant If You:

  • Are interested in cellular health support as part of a broader wellness approach
  • Have researched NAD+ and NMN through publications, podcasts, or healthcare provider discussions – you may have encountered longevity research, discussions of cellular health, or coverage of NAD+ precursors
  • Are over 40 or 50 and interested in learning more about age-related changes in cellular function – research has examined NAD+ levels across age groups
  • Are a woman navigating perimenopause or menopause and interested in cellular health research – some women include NMN as part of discussions with their healthcare providers during hormonal transitions
  • Are entering 2026 with interest in evidence-based supplementation and quality verification
  • Prefer products with verifiable quality standards and third-party testing documentation
  • Have tried standard NMN supplements and are interested in exploring alternative delivery methods – product quality and absorption vary across the category
  • Value criteria-based evaluation frameworks over promotional marketing claims

This Analysis May Be Less Relevant If You:

  • Have not consulted a healthcare provider about supplementation (recommended before starting any new regimen)
  • Are under 30 with no particular interest in cellular health research
  • Are seeking treatment for a diagnosed medical condition (NMN is not a treatment)
  • Prioritize price above quality verification
  • Prefer not to commit to consistent supplementation over several weeks

Healthcare Consultation Reminder: This framework provides informational context only. Individual supplementation decisions should involve consultation with a qualified healthcare provider, particularly for individuals with existing medical conditions or those taking medications.

Part 6: What the Research Context Suggests About Expectations

A Note on Individual Variability

According to customer feedback collected by the company, individual experiences with NMN supplementation vary widely. Some users report perceived changes in energy or focus, while others report no noticeable difference during their evaluation period. These observations are anecdotal and should not be interpreted as evidence of specific outcomes. The research context below provides general timeframe information from clinical studies, not guarantees of individual results.

Realistic Timeframe Considerations

Based on published research context, here is what the available information suggests about NMN supplementation timeframes generally:

Weeks 1-2: Initial supplementation period. This represents the beginning of consistent NAD+ precursor intake.

Weeks 2-4: Research studies often examine outcomes at or beyond the 4-week mark.

Months 1-3: Longer evaluation periods allow for more comprehensive assessment. Some research has examined NMN supplementation outcomes over 8-12 week periods.

Important Context: Individual responses to supplementation vary significantly. The timeframes above are drawn from general research context, not guarantees of specific outcomes. Some individuals may perceive changes sooner, later, or not at all.

What NMN Supplementation Is and Is Not

NMN Supplementation Is:

  • A nutritional approach to supporting NAD+ levels
  • Positioned within research context as a tool for cellular health support
  • Part of a broader wellness approach that includes sleep, nutrition, and physical activity

NMN Supplementation Is Not:

  • A treatment, cure, or prevention for any disease
  • A substitute for medical care or prescription medications
  • A guarantee of specific health outcomes
  • A replacement for foundational health behaviors

Part 7: GenuinePurity Liposomal NMN – Complete Product Information

Product Overview

GenuinePurity Liposomal NMN is manufactured by Leading Edge Health Inc., a company with over 25 years in the natural supplement sector. The company is headquartered at 300-1095 McKenzie Avenue, Victoria, BC, V8P 2L5, Canada, with US operations through LEM Processing LLC at 6130 Elton Ave, Las Vegas, NV 89107.

Supplement Facts (Per Serving)

Serving Size: 1 Vcapsule Servings Per Container: 60

Active Ingredient: β-Nicotinamide Mononucleotide 96% (NMN) – 250mg

Other Ingredients: Vegetable Cellulose (Capsule), Phospholipid Complex (NON-GMO Sunflower Lecithin, Phosphatidylcholine), Microcrystalline Cellulose, Silicon Dioxide, Vegetable Stearate.

Product Standards

Per company documentation:

  • Zero GMO
  • cGMP Certified Manufacturing
  • Made in USA
  • Zero Gluten
  • Zero Soy
  • Zero Eggs
  • Zero Dairy
  • Zero Wheat Grain
  • Zero Sugar
  • Zero Preservatives
  • 100% Natural Ingredients

Suggested Use

Per the official website, suggested use is one capsule daily with a meal. Timing preferences vary among users.

Part 8: Pricing and Purchase Information

Per the official GenuinePurity Liposomal NMN website, the product is available in single-unit and multi-unit formats.

Availability Options

According to the official website, pricing tiers and package options are available. Current pricing, availability, and any promotional terms should be confirmed directly on the official website, as these details may change.

Shipping Information

Per company documentation:

  • Free shipping to continental USA and Canada
  • International shipping is available (see official website for current destinations and terms)
  • Express courier shipping with tracking available
  • Discrete packaging

Important Note: Pricing and availability are subject to change. Verify current terms on the official website before purchase.

Part 9: Guarantee and Return Policy

Per the official website, GenuinePurity Liposomal NMN includes a 97-day money-back guarantee.

Guarantee Terms:

You are invited to try the product for 90 days, which is two containers.

If, for any reason, you are not 100% satisfied, return the two empty containers within 97 days from the time of delivery for a full refund, excluding shipping charges.

If you purchase multiple containers to take advantage of bundle pricing, any unopened containers returned along with the first two opened containers within the 97-day guarantee period are also eligible for full refund.

Returns must be received at the warehouse within 97 days of delivery. Refunds are limited to one order per customer.

What This Means for Evaluation:

The 97-day guarantee provides timeframe to evaluate the product based on the research-suggested timeframes (4-12 weeks). This structure allows for product evaluation before final purchasing commitment.

Part 10: Contact Information and Customer Support

GenuinePurity / Leading Edge Health

Customer Support Phone: Toll-Free (North America): 1-866-968-6643 International: 1-778-770-2961 Customer service hours are listed on the official website.

Email Support: [email protected]

Corporate Address: Leading Edge Health Inc. 300-1095 McKenzie Avenue Victoria, BC, V8P 2L5 Canada

US Operations: LEM Processing LLC 6130 Elton Ave Las Vegas, NV 89107

Official Website: The product is available through the company’s official website, where current terms and documentation can be reviewed: View the current GenuinePurity Liposomal NMN offer (official GenuinePurity page)

Part 11: Frequently Asked Questions

What is NMN and why is it discussed in longevity research?

NMN (nicotinamide mononucleotide) is a precursor to NAD+ (nicotinamide adenine dinucleotide), a coenzyme involved in cellular energy production and repair. Research has examined how NAD+ levels decline with age and how NMN supplementation may support NAD+ levels. This research context has generated interest in NMN as a cellular health support approach.

How is GenuinePurity Liposomal NMN different from other NMN supplements?

GenuinePurity utilizes liposomal encapsulation technology designed to enhance NMN absorption. The formulation contains 96% pure β-Nicotinamide Mononucleotide at a 250mg dose aligned with levels examined in clinical research. Third-party laboratory testing and Certificate of Authenticity documentation address quality verification concerns affecting the broader NMN category. Some reviewers and formulators in the longevity supplement space have discussed liposomal delivery as one approach intended to address absorption variability. Approaches and conclusions differ, and readers may wish to review primary research and manufacturer documentation when comparing products.

Is the 250mg dose sufficient, or should I take more?

Per company documentation, the 250mg dose aligns with dosage levels examined in published clinical research. The liposomal delivery is designed to address absorption considerations at this dosage level. Christopher Shade, PhD, founder of Quicksilver Scientific, has noted in published interviews that liposomal delivery may support more efficient nutrient uptake compared to standard delivery methods, though individual responses vary. Some users choose to take two capsules daily for a 500mg dose, consistent with higher dosage levels also examined in research. The appropriate dose for any individual should be determined in consultation with a healthcare provider.

Does NMN help with brain fog and mental clarity?

Research has examined NMN’s relationship to cognitive function through its role in NAD+ production. NAD+ is involved in cellular energy production in the brain, and research published in peer-reviewed journals has examined NAD+ and brain function. Studies in animal models have examined NMN and hippocampal function, the brain region involved in memory formation. Human research is ongoing, and the mechanistic basis for NAD+’s role in brain function is established in the scientific literature. Individual responses to supplementation vary significantly, and NMN supplementation should not be considered a treatment for any medical condition. Those with cognitive concerns should consult a healthcare provider.

Is NMN appropriate for adults over 50?

Research indicates NAD+ levels change with age, with some research examining this decline in middle-aged and older populations. This age-related change has generated interest in NMN supplementation among adults over 40 and 50. The 250mg dose in GenuinePurity Liposomal NMN aligns with dosage levels examined in research involving middle-aged and older adults. The liposomal delivery approach addresses absorption considerations that may be relevant across age groups. Consultation with a healthcare provider is recommended before beginning any supplement regimen, particularly for older adults who may have existing health conditions or take medications.

Can NMN support women during menopause or perimenopause?

Some women have explored NMN supplementation during hormonal transitions due to its role in cellular energy support. Research has examined NAD+ and its relationship to metabolic function, which may be of interest during menopause when metabolic changes are common. NAD+ is involved in brain energy production, which is relevant context for women interested in cognitive wellness during this life stage. NMN is not a treatment for menopause symptoms, and women experiencing symptoms should consult with their healthcare provider. Some women include NMN as part of their broader wellness approach during hormonal transitions, in consultation with their healthcare providers.

Is liposomal NMN better than regular NMN?

This is an active discussion in the longevity supplement space, and perspectives vary among researchers. Published research on liposomal delivery has shown that phospholipid encapsulation can improve bioavailability of certain compounds by protecting them from digestive degradation. Christopher Shade, PhD, has noted in published interviews that the body’s natural NMN transport system uses liposome-like vesicles, suggesting liposomal delivery may align with biological mechanisms. Other researchers have noted that standard NMN demonstrates adequate absorption in clinical studies. Product quality and absorption efficiency vary across the NMN supplement category, depending on sourcing, formulation, and delivery method. For individuals who have tried standard NMN without experiencing anticipated results, the liposomal approach represents an alternative worth discussing with a healthcare provider. GenuinePurity’s formulation is designed for those who prioritize absorption optimization as part of their evaluation criteria.

When should I take GenuinePurity Liposomal NMN?

Per the official website, suggested use is one capsule daily with a meal. Timing preferences vary among users.

How long before I might notice changes?

Based on general research context, clinical studies on NMN have examined timeframes ranging from 2 weeks to 12 weeks. According to customer feedback collected by the company, individual experiences vary widely – some users report perceived changes within the first few weeks, while others report no noticeable difference. These observations are anecdotal and should not be interpreted as evidence of specific outcomes. The 97-day guarantee provides timeframe for product evaluation. Individual responses to supplementation vary significantly based on factors including age, baseline health status, lifestyle, and other individual variables.

Is GenuinePurity Liposomal NMN safe?

Per company documentation, the product is manufactured in cGMP-certified, FDA-registered US facilities with third-party testing. The formulation is free from GMOs, gluten, soy, dairy, and artificial preservatives. However, as with any supplement, consultation with a healthcare provider before use is recommended, particularly for individuals with existing medical conditions or those taking medications.

Is NMN legal as a dietary supplement?

Public reporting in 2025 discussed FDA correspondence related to NMN and dietary supplement regulatory status. Readers should review the most current regulatory information and consult qualified professionals for interpretation.

What is your refund policy?

GenuinePurity offers a 97-day money-back guarantee. Try the product for 90 days (two containers). If not satisfied, return empty containers within 97 days of delivery for full refund excluding shipping. Unopened containers from multi-bottle orders are also refundable. One refund per customer.

Where can I purchase GenuinePurity Liposomal NMN?

The product is available through the company’s official website, where current terms and documentation can be reviewed: View the current GenuinePurity Liposomal NMN offer (official GenuinePurity page)

Summary: Evaluating “Best NMN Supplement 2026” Through Quality Criteria

The phrase “best NMN supplement 2026” reflects a reasonable question from consumers seeking cellular health support as they enter the New Year with wellness intentions.

This industry analysis has examined GenuinePurity Liposomal NMN against five evaluation criteria: purity verification, dosage research alignment, manufacturing standards, company accountability, and authenticity documentation.

Third-Party Recognition Context

Some reviewers and formulators in the longevity supplement space have discussed liposomal delivery as one approach intended to address absorption variability. Approaches and conclusions differ, and readers may wish to review primary research and manufacturer documentation when comparing products.

Key Findings:

Formulation Approach: Liposomal delivery technology addresses absorption considerations that affect the NMN supplement category broadly. Product quality and absorption efficiency vary across the category depending on sourcing, formulation, and delivery method. For individuals interested in absorption optimization as an evaluation factor, the liposomal approach offers differentiated consideration.

Quality Standards: 96% purity with third-party verification, cGMP manufacturing in FDA-registered US facilities, and 20+ years of company track record in the natural supplement sector.

Dosage Context: 250mg per serving aligns with dosage levels examined in published clinical research on NMN and NAD+ levels in human participants.

Consumer Protection: 97-day money-back guarantee provides timeframe for product evaluation. Guarantee terms are per company documentation and should be verified on the official website.

Regulatory Clarity: Public reporting in 2025 discussed FDA correspondence related to NMN and dietary supplement regulatory status, providing category-level context.

Criteria-Based Evaluation Reminder

As outlined at the beginning of this analysis, “best” is defined through the five evaluation criteria framework – purity verification, dosage research alignment, manufacturing standards, company accountability, and authenticity documentation. Readers are encouraged to weight these factors according to their individual priorities and consult with healthcare providers regarding supplementation decisions.

The Purchasing Decision

This analysis provides a framework for informed evaluation based on the five criteria outlined: purity verification, dosage research alignment, manufacturing standards, company accountability, and authenticity documentation. “Best” in this context means alignment with these objective quality markers – readers should weight these factors according to their individual priorities.

The decision of whether NMN supplementation aligns with individual goals, and whether GenuinePurity Liposomal NMN represents the right choice within the category, remains with each reader in consultation with their healthcare provider. For those entering 2026 with cellular health support as a priority, the five criteria framework offers objective evaluation structure, and for those with questions or need for additional information, customer support is accessible at 1-866-968-6643 or readers can view the current GenuinePurity Liposomal NMN offer (official GenuinePurity page) for complete product documentation.

Related Industry Coverage

For additional context on GenuinePurity Liposomal NMN, readers may review prior industry analyses examining the product’s quality standards and formulation approach:

Best NMN Brand Ranked: Top-Rated Anti-Aging Longevity Support Reviewed

Genuine Purity Liposomal NMN: Best NMN Supplement Brand by Leading Edge Health

Disclaimers

FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. GenuinePurity Liposomal NMN is a dietary supplement designed to support healthy NAD+ levels. It is not intended to diagnose, treat, cure, or prevent any disease.

Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Individual results may vary. Consult a qualified healthcare professional before starting any new supplement regimen, especially if you have existing medical conditions, are taking medications, are pregnant or nursing, or are under 18 years of age.

Research Disclaimer: Research cited in this article reflects ingredient-level and general NAD+/NMN research published in peer-reviewed journals. GenuinePurity Liposomal NMN as a finished product has not been independently clinically studied. Research findings about NMN as an ingredient provide context but do not guarantee specific outcomes.

Affiliate Disclosure: This article contains affiliate links. If you purchase through these links, a commission may be earned at no additional cost to you. This compensation does not influence the accuracy or integrity of the information presented.

Pricing Disclaimer: Pricing information reflects terms available at time of publication and is subject to change. Verify current pricing, availability, and promotional offers on the official website.

Guarantee Terms: Money-back guarantee terms as stated are per the official company website at time of publication. Verify current guarantee terms before purchase.

Contact:

Leading Edge Health Inc. 300-1095 McKenzie Avenue Victoria, BC, V8P 2L5, Canada

Customer Support: 1-866-968-6643 Email: [email protected] Website:View the current GenuinePurity Liposomal NMN offer (official GenuinePurity page)

CONTACT: Customer Support Phone: Toll-Free (North America): 1-866-968-6643

International: 1-778-770-2961

Customer service hours are listed on the official website.

Email Support: [email protected]



Source link

2 01, 2026

XRP Price Prediction: XRP Could Target $1.90 if Falling Wedge Breakout Gains Momentum

By |2026-01-02T00:52:40+02:00January 2, 2026|Crypto News, News|0 Comments

XRP is drawing renewed market attention as a combination of technical patterns and macroeconomic developments may set the stage for a potential rally toward $1.90 in early 2026.

The digital asset has been consolidating near $1.84–$1.86 after months of sideways trading, forming a falling wedge pattern. This formation often precedes bullish reversals, but crypto’s volatility means confirmation is critical. Coupled with recent Federal Reserve liquidity injections, analysts suggest conditions may be favorable for a short-term upward move, if key support levels hold.

XRP Price Today and Market Context

As of January 1, 2026, XRP is trading at $1.859, up 0.50% over 24 hours, with a trading volume of 1.77 billion XRP. Moderate volume suggests measured accumulation rather than aggressive buying, while the ongoing SEC lawsuit against Ripple, filed in 2020, continues to influence market sentiment and price volatility. TradingView analyst Leo524 noted that XRP has been in a strong downtrend over the past five months, repeatedly rejecting the descending trendline, and currently sits near a major green support zone, historically a launchpad for recovery moves.

XRP tests a key support zone after months of downtrend, with a potential recovery move if it breaks above the descending trendline. Source: Leo524 via X

“If the support zone holds and XRP breaks above the descending trendline, we can expect a potential recovery move,” Leo524 said.

From a technical perspective, traders should watch for a daily close above the descending trendline (~$1.88) with above-average volume as the first confirmation signal, while a breach of the $1.82–$1.84 support zone would weaken the bullish thesis. Broader market catalysts, including Bitcoin’s performance and institutional inflows, will also play a role. If conditions align, a move toward $1.90 becomes plausible, though it remains contingent on confirmation signals rather than guaranteed.

Technical Signals Point to a Potential Bullish Reversal

CRYPTO CAPTAIN (@UniverseTwenty) highlighted XRP’s daily chart, noting the classic falling wedge pattern: “The XRP breakout is imminent from this falling wedge pattern,” the analyst stated.

XRP Price Prediction: XRP Could Target .90 if Falling Wedge Breakout Gains Momentum

XRP gears up for a bullish surge as the falling wedge pattern signals a potential breakout toward $1.90. Source: @UniverseTwenty via X

On the daily chart, the wedge apex converges with the $1.82–$1.84 demand zone, which acts as a practical invalidation level. A daily close below this range would weaken the bullish thesis and signal that the pattern has failed.

Historical studies, including Bulkowski’s Encyclopedia of Chart Patterns, report a 68–74% success rate for falling wedges in equity markets. However, crypto markets are generally more volatile and leverage-driven, making pattern reliability more variable. In this context, analysts emphasize the need for volume confirmation to validate the breakout.

Fed Liquidity Boost: Macro Tailwinds for XRP

A key macro factor is the $74.6 billion repo injection by the Federal Reserve on December 31, 2025. X Finance Bull (@Xfinancebull) suggested this could benefit XRP and crypto more broadly, noting that liquidity is entering markets with tangible utility: “XRP has clarity, rails, and a fixed supply. Fiat expands. XRP doesn’t. That’s how this ends,” the analyst on X.

Fed Liquidity Boost: Macro Tailwinds for XRP

Fed pumps $74.6B liquidity, boosting XRP as smart capital flows into crypto with real utility and XRP’s fixed supply standing out. Source: @Xfinancebull via X

While increased liquidity may encourage investment in risk assets, it is important to distinguish correlation from causation. Historically, Fed repo operations primarily stabilize short-term money markets; their direct impact on XRP depends on risk-on sentiment and institutional flows.

Institutional adoption trends, such as the 2025 crypto ETF boom and the launch of Ripple’s RLUSD stablecoin, also provide potential support for XRP. Experts like Lyn Alden note that the record repo usage was a year-end balance sheet adjustment, not a financial crisis, which tempers expectations for guaranteed price jumps.

Final Thoughts

XRP’s setup combines technical patterns with macro liquidity support, pointing to a cautiously optimistic near-term scenario toward $1.90. The falling wedge indicates weakening selling pressure, and institutional interest alongside Fed liquidity provides potential upside.

Final Thoughts

XRP was trading at around 1.85, up 0.50% in the last 24 hours at press time. Source: XRP price via Brave New Coin

Traders should monitor the $1.82–$1.84 support zone, a trendline breakout around $1.88, and volume confirmation as key signals. Failure to hold these levels would delay or invalidate the bullish scenario. Despite SEC uncertainties, XRP’s utility, fixed supply, and growing adoption continue to support its potential, making $1.90 plausible, but not guaranteed.

Source link

1 01, 2026

Brent eyed near $55 early as supply glut tests OPEC+ resolveNEW YORK, January 1, 2026, 15:08 ET

By |2026-01-01T23:39:32+02:00January 1, 2026|Forex News, News|0 Comments


  • Brent ended 2025 at $60.85 a barrel after a roughly 19% annual drop; U.S. WTI settled at $57.42, down nearly 20%.
  • BNP Paribas expects Brent to dip to $55 in the first quarter of 2026 before rebounding toward $60, with demand flat and supply still growing.
  • Forecasters see a 2026 surplus ranging from the IEA’s 3.84 million barrels per day to Goldman Sachs’ 2 million bpd, keeping pressure on prices.

Brent crude is expected to slide toward $55 a barrel in early 2026 as analysts warn that supply will outpace demand after oil posted its steepest annual fall since 2020.

The forecast matters as governments and central banks start the year watching energy costs for inflation, while producers weigh drilling plans and hedging strategies for 2026.

Traders are also looking to OPEC+ for direction ahead of a January 4 meeting, with the group’s next policy move seen as pivotal if prices drift into the low $50s.

Brent futures settled at $60.85 a barrel on Dec. 31, while U.S. West Texas Intermediate (WTI) ended at $57.42. Brent fell about 19% in 2025 and WTI nearly 20%, extending a multi-year losing streak for benchmarks.

BNP Paribas commodities analyst Jason Ying expects Brent to dip to $55 in the first quarter before recovering to $60 for the rest of 2026. “We think U.S. shale producers were able to hedge at high levels,” Ying said, referring to using derivatives to lock in future selling prices and keep production steady even if spot prices fall. Reuters

Morgan Stanley’s global oil strategist Martijn Rats said OPEC+ would likely respond with cuts only if prices fall substantially further, pointing to the low $50s as the area that could force the group’s hand, according to Reuters.

Most analysts expect a 2026 surplus, with estimates ranging from the International Energy Agency’s 3.84 million barrels per day to Goldman Sachs’ 2 million bpd. A surplus means the world is pumping more oil each day than it consumes, swelling inventories and weighing on prices.

OPEC+, which groups the Organization of the Petroleum Exporting Countries and allies including Russia, paused output hikes for the first quarter of 2026 after releasing about 2.9 million bpd into the market since April, Reuters reported.

U.S. data have also reinforced the market’s focus on demand. The Energy Information Administration said crude stockpiles fell by 1.9 million barrels in the week ended Dec. 26, while gasoline rose by 5.8 million barrels and distillates, including diesel and heating oil, climbed by 5 million barrels on strong refining runs. ( Reuters)

In the same report, “total product supplied” — a widely watched proxy for demand — dropped by 934,000 bpd to 19.38 million bpd, a decline that can signal softer consumption as the holiday period fades.

Geopolitics remains the wild card, analysts said, even with the market leaning bearish on fundamentals. The United States imposed new sanctions on four companies it said were operating in Venezuela’s oil sector and targeted associated tankers, a move Washington said was part of an intensified pressure campaign on President Nicolas Maduro. ( Reuters)

The U.S. action followed a broader push against what officials call a “shadow fleet” — older ships with opaque ownership and limited insurance that transport sanctioned oil — and came after a U.S. blockade announced earlier in December that Reuters said helped cut Venezuela’s exports to about half of November levels.

For now, the tug-of-war is clear: surging supply expectations and swelling inventories point lower, while OPEC+ policy and sanctions-driven disruptions could keep a floor under prices.

The next test comes quickly. Traders will watch the Jan. 4 OPEC+ meeting and early-2026 demand signals for clues on whether Brent stabilizes near $60 — or slips toward the mid-$50s that some banks have penciled in.



Source link

1 01, 2026

‘Men’s Health’ Magazine Supplement Buying Guide

By |2026-01-01T22:58:10+02:00January 1, 2026|Dietary Supplements News, News|0 Comments


ELSEWHERE ON THE internet, you’re going to see a whole lot of nonsense about supplements.

You might hear—either from so-called “experts” or from supplement companies themselves—that certain pills or powders can help prevent and treat disease. You might read that supplements can dramatically change how you look and feel. You might even witness that certain products have the ability to detox your body from harmful environmental toxins.

If all of this sounds too good to be true, that’s because it largely is. We know this because for close to four decades, Men’s Health has tracked the scientific research and spoken with trusted authorities in the dietary supplement space.

We’ve taken all that scientific research and those conversations with credentialed experts and built the ultimate guide to supplement buying.

Download the Ultimate Supplement Guide

In this definitive Men’s Health guide you’ll find:

  • How to ensure you’re buying a safe and effective supplement, whichever supplement you’re looking to buy
  • An in-depth look into muscle-building supplements, including protein powder, creatine, and pre-workout
  • An analysis of gut health supplements, which covers prebiotics and probiotics
  • Recommendations on immunity, disease prevention, and brain health supplements
  • Plus: A reference chart for tons of additional supplements that gives our assessment on which of the claims are backed by science—and which aren’t.

In short, if you’ve ever had a question about a supplement, you’re almost guaranteed you’ll find an answer to it in this guide.

Without this information, know that there’s one big thing you should watch out for: lack of oversight.

Supplement manufacturers can get away with making claims about what’s in their products and what they can do for you, health-wise, because they don’t have provide evidence to any governing body. In the United States, the FDA can ban ingredients, issue recalls for supplements already on the market, and send warning letters to supplement companies, but the agency largely does not regulate supplements before they go on sale.

That leaves you, as a consumer, to figure out if a product is safe and effective. And if that feels overwhelming, we got you.


MEN’S HEALTH MVP is a community of guys who are passionate about building their physical, mental, and emotional fitness, just as you are. And our MH MVP program is about giving you as many tools as possible to make that possible. This Hypertrophy program is just one of the vast array of features available that’ll help you become your best self.

  • Unlock all stories and curated training plans for all fitness goals, as well as cutting-edge reviews and in-depth breakdowns of new workout principles at menshealth.com
  • Get every print issue delivered straight to your mailbox
  • Receive a weekly members-only newsletter with deep insights from MH’s fitness experts
  • Access hundreds of streaming video workouts on demand

JOIN MVP PREMIUM

Paul Kita is a Deputy Editor at Men’s Health, where he has covered food, cooking, nutrition, supplements, grooming, tech, travel, and fatherhood at the brand for more than 15 years. He is also the author of two Men’s Health cookbooks, Guy Gourmet and A Man, A Pan, A Plan, and the winner of a James Beard Award.



Source link

1 01, 2026

Mutuum Finance (MUTM) and Ripple (XRP) Price Prediction if Bitcoin (BTC) Hits $250,000

By |2026-01-01T22:51:34+02:00January 1, 2026|Crypto News, News|0 Comments

A price explosion of Bitcoin (BTC) to $250,000 in the year 2026 may lift the overall market, with established as well as new cryptos touching new heights. Top cryptos such as XRP will be on a winning streak with the institutional approach and developments in the payments sector. But it may be the new cheap crypto coin Mutuum Finance with a price of $0.04 that may attract attention.

XRP Price

In the event that the price of Bitcoin (BTC) is set to have a price cycle top at $250,000, there might be an increase in the price of XRP as well. Although the year 2025 has turned out very badly for the whole altcoin market, as it has fallen as low as 42% in value, it is very interesting that the price of XRP has fallen merely by 15%. This is in line with the fast expansion that Ripple is making, which includes more than $2.7 billion worth of acquisitions in payments, treasury management software and trading infrastructure.

Another factor which has worked in favor of XRP is the improvement in the regulatory environment, where Ripple has finally closed its case in the SEC after a couple of years, paving the way for new investments. If a price rise is to happen, then it is likely that the defensive holding qualities of XRP, along with the resilience it has shown in the past, may help it to deliver huge profits. However, XRP is unlikely to be the next big crypto. Factors such as its large market cap could lead to minimal growth. On the other hand, Mutuum Finance could easily shock the market with its upside. 

MUTM Presale Phase 7 is Now Open

Mutuum Finance (MUTM) has now launched Phase 7 of its presale, and token prices are set at $0.04. It follows Phase 6, where the token was set at $0.035, an increase of 15%. The project has shown incredible momentum, and analysts see the token breaking past its $0.06 market debut price in no time. 

If Bitcoin hits $250,000 in the next bull run, Mutuum Finance could soar as high as 50x from its current price to hit $2. This will position MUTM as one of the best performing DeFi cryptos in the 2026 bull run. In addition, an investment of just $100 at today’s price will balloon to $5000 if this rally materializes. 

Mutuum Finance (MUTM) and Ripple (XRP) Price Prediction if Bitcoin (BTC) Hits 0,000

Since the presale began, more than 18,630 investors have participated, and over $19.5 million of funding has been raised. The dual nature of the token, together with the soon-to-be-launched V1 Sepolia Testnet, continues to attract investors, as there is genuine utility in play. MUTM has been audited by Certik, where the project emerged with a 90/100 token scan score, showing it’s a safe investment opportunity. White hackers can also participate in a $50,000 bug bounty program to identify possible vulnerabilities in the project. These measures show how seriously the team behind Mutuum Finance takes security. As a result, smart money investors recognize MUTM as a high-potential crypto to buy now.

Passive Income for Users  

An important aspect of Mutuum Finance is its mtToken system, which rewards individuals who bring assets to lend to the platform. While traditional assets only generate interest when they are withdrawn, mtTokens provide investors with the opportunity to generate passive income in real-time while still enjoying liquidity. This is an innovative platform that improves MUTM’s usable utility in the marketplace and solidifies it as the most promising cheap crypto coin to invest in 2026.

Halborn Security Audit & Testnet Launch 

Aside from an audit by CertiK, Halborn Security has also conducted an independent audit of MUTM, concentrating on its lending and borrowing contracts. The MUTM team has integrated the audit’s feedback and is now preparing for Sepolia testnet debut. The tesnet will mark the project’s first public deployment. This version will introduce core components including:

  • Liquidity Pools for lending and borrowing
  • mtTokens representing user deposits and accrued yield
  • Debt Tokens tracking borrowed positions
  • An Automated Liquidator Bot to manage under-collateralized loans

Initially, the protocol will support ETH and USDT as primary assets for lending, borrowing, and collateral. The testnet launch allows users and users to interact with the platform, provide feedback, and help optimize the system before mainnet release.

Buy XRP or MUTM?

If Bitcoin (BTC) reaches $250,000 in 2026, both XRP and Mutuum Finance are primed for rallies. However, while XRP’s upside could easily be limited by its large market cap, MUTM shows potential for up to 50x returns. With a cost of just $0.04 in Phase 7, MUTM already boasts over $19.5M in funds raised in its fast-growing presale. This makes MUTM not only a crypto to buy now but a no-brainer pick over XRP.

For more information about Mutuum Finance (MUTM) visit the links below:

Website: https://mutuum.com/

Linktree: https://linktr.ee/mutuumfinance

Source link

1 01, 2026

Natural gas price slide drags UNG stock lower as warm U.S. forecast cools winter demand

By |2026-01-01T21:38:42+02:00January 1, 2026|Forex News, News|0 Comments


NEW YORK, January 1, 2026, 13:00 ET — Market closed

  • U.S. natural gas-linked fund UNG fell 6.7% in the last session as Henry Hub futures dropped on warmer forecasts and a light storage draw.
  • Gas producers slipped while LNG exporter Cheniere edged up, with traders focused on weather updates and the next EIA storage report.

The United States Natural Gas Fund (UNG) sank 6.7% on Wednesday, the last U.S. trading session of 2025, tracking a sharp pullback in U.S. natural gas prices after traders leaned into a warmer weather outlook for early January.

The move matters because winter pricing is still dominated by short-term swings in heating demand, and forecasts can change quickly. A warmer-than-normal pattern typically means less gas burned for heat and fewer withdrawals from storage.

It also lands as U.S. liquefied natural gas (LNG) exports keep running at high levels, tying domestic prices more closely to export demand. That support can be offset in the near term when weather turns milder and production stays high.

UNG closed at $12.26, after trading between $12.18 and $12.69 during the session.

Among gas-heavy producers, EQT fell 1.9%, Antero Resources slid 1.8% and Range Resources dropped 2.3%. LNG exporter Cheniere Energy rose 0.5%.

In the futures market, front-month February Henry Hub contracts were down 5.7% at $3.745 per million British thermal units by 12:41 p.m. ET on Wednesday, pressured by warmer forecasts for next week and a smaller-than-expected storage withdrawal, even as record gas flows to LNG export facilities in 2025 kept the market on track for a second straight annual gain. BOE Report

Meteorologists projected above-normal temperatures across the country through Jan. 14, Reuters reported, and Heating Degree Days — a measure of energy demand to heat buildings — fell to 413 from 439 a day earlier. BOE Report

The Energy Information Administration said utilities withdrew 38 billion cubic feet (bcf) from storage for the week ended Dec. 26. One bcf is a billion cubic feet of gas. BOE Report+1

Working gas in storage stood at 3,375 bcf, the EIA data showed. That left inventories about 58 bcf above the five-year average for this time of year, based on the agency’s historical comparisons. EIA Information Releases

On the supply side, LSEG data showed Lower 48 output averaging 110.1 billion cubic feet per day (bcfd) in December, a record, while average feedgas deliveries to the eight big U.S. LNG export plants reached 18.5 bcfd in December. Feedgas is gas delivered to liquefaction terminals for export. BOE Report

“Given this weather and the drawdown number, there’s really not a whole lot of room for the natural gas prices to go up,” said Zhen Zhu, a managing consultant at C.H. Guernsey and Company in Oklahoma City. BOE Report

Before the next session: U.S. markets reopen on Jan. 2, and traders are likely to keep treating weather model shifts and LNG feedgas flows as the main near-term catalysts. The next weekly storage report from the EIA is scheduled for Jan. 8, following Wednesday’s holiday-shifted release. EIA Information Releases+2EIA Information Releases+2

UNG’s Wednesday low of $12.18 is the first level many short-term traders will watch for signs of another wave of selling, while the day’s high of $12.69 marks the nearby upside hurdle if gas prices rebound.



Source link

1 01, 2026

BTCUSD Price Prediction: Aiming for $91,771 Amidst RSI at 42.63

By |2026-01-01T20:50:55+02:00January 1, 2026|Crypto News, News|0 Comments

Bitcoin’s current price has traders talking as it sits at $87,497.94, showing a slight decline of 1.03%. With an RSI of 42.63 signaling potential future movements, investors are speculating whether BTCUSD can reach its forecasted target of $91,771. Let’s dive into the technical indicators and market trends to understand what’s driving Bitcoin’s fluctuations.

Current Price Analysis

As of now, Bitcoin is priced at $87,497.94, down 1.03% from its previous close of $88,407.73. Volume is significantly lower at 760,042,936 compared to the average of 63,741,527,337. These figures suggest a pause in trading momentum, reflected in the daily low of $87,082.64 and a high of $89,100.00. The market cap stands firm at approximately $1.7 trillion, indicating Bitcoin’s resilience amid volatility.

Technical Indicators Overview

The RSI at 42.63 suggests that the market isn’t heavily overbought or oversold, leaving room for potential upward movement. The MACD stands at -1,943.84, with a histogram of 440.83, indicating a bearish sentiment that might be shifting. ADX is strong at 31.67, showing a solid trend, which could be pivotal for market direction in the coming weeks.

Forecast and Future Price Target

Forecasts predict Bitcoin could hit $91,771 this month, supported by technical patterns and market sentiment. The quarterly projection is even higher at $137,052.42, while yearly expectations predict a mild dip to $83,932.49. These forecasts reflect Bitcoin’s potential to overcome short-term setbacks, as historical resilience shows in its three-year growth of 517.94%. Forecasts can change due to macroeconomic shifts, regulations, or unexpected events affecting the crypto market.

Market Sentiment and News Impact

Recent news highlights Bitcoin’s evolving role in financial markets. While no major news events have dramatically shifted prices in the last 24 hours, consistent attention from finance platforms underscores Bitcoin’s relevance. This coverage helps maintain trader interest and can subtly impact sentiment, influencing trading volumes and price movements. As Meyka AI suggests, keeping an eye on such developments is crucial for informed trading decisions.

Final Thoughts

Bitcoin’s price fluctuations underline the complexity of crypto markets, where a multitude of factors can shift sentiment and direction. With predictions aiming for $91,771, traders should remain alert to indicators and news that could influence the landscape. Continual analysis and adaptation will be key as forecasts evolve.

FAQs

What is the current BTCUSD price?

As of the latest data, BTCUSD is priced at $87,497.94, reflecting a 1.03% decrease from the previous close of $88,407.73. For more detailed updates, visit this BTCUSD page.

What does the RSI indicate about BTCUSD?

The RSI is at 42.63, suggesting Bitcoin is neither overbought nor oversold, which may indicate potential upward movement depending on market conditions.

What are the forecasts for BTCUSD?

Bitcoin is forecasted to reach $91,771 this month and $137,052.42 quarterly, with a potential yearly dip to $83,932.49. Long-term predictions include $108,532.96 over three years.

How does market volume affect BTCUSD price?

The current volume of 760,042,936 is below the average, indicating reduced trading activity, which can contribute to price stabilization or minor fluctuations.

What factors could change BTCUSD forecasts?

Forecasts can change due to macroeconomic shifts, regulations, or unexpected events affecting the crypto market, impacting sentiment and price direction.

Disclaimer:


Cryptocurrency markets are highly volatile. This content is for informational purposes only.
The Forecast Prediction Model is provided for informational purposes only and should not be considered financial advice.
Meyka AI PTY LTD provides market data and sentiment analysis, not financial advice.
Always do your own research and consider consulting a licensed financial advisor before making investment decisions.

Source link

1 01, 2026

2025 Brain Health Roundup | Nutritional Outlook

By |2026-01-01T16:54:42+02:00January 1, 2026|Dietary Supplements News, News|0 Comments


In this feature article from our April issue of Nutritional Outlook, neurologist Alexander Zubkov presents an integrative approach to long-term cognitive health, focusing on the most studied nutrients and herbs for brain health, when to start taking supplements, and the role of gut-brain connection.

“We now understand that brain health is deeply connected to what we consume,” Zubkov explains. “The neurons in our brain rely on a steady supply of essential nutrients, healthy fats, and antioxidants to function optimally. Deficiencies in key vitamins and minerals—such as B vitamins, magnesium, and omega-3 fatty acids—can impair neurotransmitter production and accelerate cognitive decline.”

He adds, “For those looking to maintain optimal cognitive health, the key is proactive maintenance. Whether through dietary changes, targeted supplementation, or lifestyle modifications, we all have the power to influence our brain’s longevity. And in the evolving field of neurology, I believe that embracing an integrative mindset will be the future of brain health care.”

Here, David DeSouza, president of Monterey Bay Herb Co., highlights popular nootropic herbs and strategies for formulating high quality and effective products that responsibly communicate benefits in line with federal regulations. He explains the leading botanicals in the category, sourcing and efficiency, and responsible marketing strategies.

“The rise of botanical nootropics signals a broader shift in how consumers approach mental performance,” he explains. “As the brain health category expands, natural ingredients offer a compelling foundation for products that align with both wellness goals and clean-label values. However, successful innovation depends on more than ingredient choice. Brands that commit to clinical rigor, responsible sourcing, and ethical storytelling will be best positioned to lead—and sustain—growth in the cognitive health space.”

In this article, the Cognitive Health Committee of the Institute for the Advancement of Food and Nutrition Sciences (IAFNS) explores the significant gap in knowledge about the impact nutrition has on adolescent cognitive development.

To highlight opportunities to learn more about the impact of nutrition during adolescence, the IAFNS committee initiated a systematic review, led by researchers at Swansea University, focused on a comprehensive age range of 8 to 19 years, author Marie Latulippe, MS, MBA, RDN explains. In total, 48 randomized controlled trials and 25 prospective cohort studies met the inclusion criteria. Because of lack of consistency across studies, it was difficult to discern the impacts of specific nutrients on cognition and academic achievement. There were beneficial effects for some nutrients such as Vitamin D, choline, polyphenols, and whole grains, but evidence was sparse. Although conclusions were elusive, this review points to a significant gap in knowledge about how nutrition can be impactful in adolescence.

In our January/February issue of Nutritional Outlook, Editor Madeline Colli explains how vitamin B12 is gaining steam in the cognitive health category and proving to be a supplement to watch. Colli spotlights the core mechanisms of the vitamin, consumer interest, the variety of its forms, and its growth in the market.

“The importance of vitamin B12 for human health, particularly cognitive health, is well established,” Colli explains. “Naturally, vitamin B12 is a valuable addition to these formulas as manufacturers combine herbs and proprietary ingredients with tried and true vitamins and minerals that speak to a basic understanding of nutrition.”

In our March issue of Nutritional Outlook, Editor Sebastian Krawiec explores the role of nutrition in reducing the risk of age-related cognitive impairment, and why more research is necessary to validate claims and promote innovation, referencing multiple published research studies.

“Confidence in supplements and their cognitive health claims varies, with most medical professionals not putting much stock in them largely due to the lack of large clinical trial data validating these benefits,” Krawiec explains. “Many take issue with what they view as deceptive and predatory marketing since people already experiencing cognitive deficits are unlikely to see any measurable improvements. That is not to say that certain nutrients and herbs cannot support cognitive health, simply that more substantiation is required.”



Source link

1 01, 2026

MATIC Price Prediction: Targeting $0.45-$0.52 Recovery by February 2026 Despite Current Bearish Momentum

By |2026-01-01T16:49:13+02:00January 1, 2026|Crypto News, News|0 Comments



Felix Pinkston
Jan 01, 2026 11:42

MATIC price prediction shows potential for 18-37% gains to $0.45-$0.52 range within 4-6 weeks, contingent on breaking critical $0.58 resistance level amid neutral RSI conditions.





MATIC Price Prediction: Targeting $0.45-$0.52 Recovery by February 2026

Polygon’s native token MATIC is positioned at a critical juncture as we enter 2026, trading at $0.38 with technical indicators presenting a mixed but cautiously optimistic outlook. Our comprehensive MATIC price prediction analysis reveals potential for significant upside movement, though key resistance levels must be conquered first.

MATIC Price Prediction Summary

MATIC short-term target (1 week): $0.42 (+10.5%)
Polygon medium-term forecast (1 month): $0.45-$0.52 range (+18% to +37%)
Key level to break for bullish continuation: $0.58
Critical support if bearish: $0.35-$0.33

Recent Polygon Price Predictions from Analysts

The latest analyst sentiment shows a cautious but optimistic Polygon forecast consensus. Blockchain.News presents the most bullish MATIC price prediction with targets of $0.45-$0.52 in the medium term, emphasizing the critical importance of breaking the $0.58 resistance barrier. This aligns with our technical analysis showing this level as the primary obstacle to bullish continuation.

CoinCodex’s AI-driven model offers a more conservative short-term MATIC price target of $0.1040, suggesting minimal movement, while Coinbase projects a modest long-term target of $0.13 over five years. The divergence in these predictions reflects the current uncertainty in MATIC’s direction, with most analysts agreeing that breaking key resistance levels will be crucial for confirming any bullish momentum.

MATIC Technical Analysis: Setting Up for Potential Breakout

Current Polygon technical analysis reveals MATIC trading below all major moving averages except the 7-day SMA ($0.37), indicating the token is still in a corrective phase. The price sits at $0.38, positioned at the daily pivot point, suggesting a critical decision zone.

The RSI reading of 38.00 places MATIC in neutral territory with room for upward movement without reaching overbought conditions. However, the MACD histogram at -0.0045 shows bearish momentum persists, though the relatively small magnitude suggests this bearish pressure may be weakening.

Volume analysis shows moderate trading activity at $1,074,371 on Binance spot, which needs to increase significantly to support any meaningful price breakout. The Bollinger Bands position at 0.29 indicates MATIC is trading in the lower portion of its recent range, potentially setting up for a mean reversion trade.

Polygon Price Targets: Bull and Bear Scenarios

Bullish Case for MATIC

Our bullish MATIC price prediction scenario targets the $0.45-$0.52 range within 4-6 weeks. This represents the convergence zone of the 50-day SMA ($0.45) and the upper Bollinger Band resistance around $0.52.

For this bullish case to materialize, MATIC must first reclaim the 20-day EMA at $0.42, then challenge the critical $0.58 resistance level. A decisive break above $0.58 would likely trigger momentum buying, potentially pushing MATIC toward the $0.65-$0.70 zone where the 200-day SMA currently resides.

Key catalysts supporting this Polygon forecast include potential network upgrades, increased DeFi activity, and broader cryptocurrency market recovery. The technical setup suggests MATIC has established a base around current levels, with the 52-week low of $0.37 providing strong psychological support.

Bearish Risk for Polygon

The bearish scenario for our MATIC price prediction involves a breakdown below the immediate support at $0.35, which could trigger selling pressure toward the strong support zone at $0.33. This level represents both a technical support confluence and proximity to the 52-week low.

Risk factors include continued bearish MACD momentum, failure to reclaim moving average resistance levels, and potential broader market weakness. A break below $0.33 could signal a more prolonged correction, potentially testing the $0.28-$0.30 zone.

Should You Buy MATIC Now? Entry Strategy

Based on our Polygon technical analysis, the current risk-reward setup presents mixed signals. Conservative buyers should wait for a clear break above $0.42 (20-day EMA) before initiating positions, with a MATIC price target of $0.45-$0.52.

Aggressive traders might consider accumulating near current levels ($0.38) with strict stop-losses below $0.35. The key question of “buy or sell MATIC” depends on risk tolerance, but the technical setup suggests more upside potential than downside risk at current levels.

Position sizing should remain conservative given the bearish MACD momentum, with maximum 2-3% portfolio allocation recommended. Stop-loss levels should be placed below $0.35 for long positions, representing approximately 8% downside risk from current levels.

MATIC Price Prediction Conclusion

Our comprehensive MATIC price prediction forecasts a potential 18-37% upside move to the $0.45-$0.52 range over the next 4-6 weeks, contingent on breaking the critical $0.58 resistance level. The confluence of analyst targets and technical indicators supports this Polygon forecast, though execution remains dependent on broader market conditions.

Confidence Level: Medium (65%)

Key indicators to monitor for confirmation include MACD turning positive, RSI breaking above 45, and volume expansion on any upward moves. Invalidation of this bullish MATIC price prediction would occur on a decisive break below $0.35, potentially triggering deeper correction toward $0.33 support.

Timeline for this prediction spans 4-6 weeks, with the first major test occurring at the $0.42 resistance level within the next 7-10 days.

Image source: Shutterstock


Source link

1 01, 2026

GBP/USD Forecast 2026: Policy Divergence, Volatility, and Key Levels to Watch

By |2026-01-01T15:02:52+02:00January 1, 2026|Forex News, News|0 Comments

Morgan Stanley presents the most bullish scenario, projecting GBP/USD at 1.47 by end-2026, with upside extensions toward 1.50 if US growth decelerates sharply. Their base case assumes three additional Fed cuts in the first half of 2026, driving the fed funds rate toward 3.00% and compressing US rate differentials. Still, even Morgan Stanley has moderated its earlier conviction, acknowledging that dollar weakness may prove more measured and front-loaded.

MUFG adopts a middle-ground approach, projecting GBP/USD near 1.40 by mid-2026, consistent with a gradual rather than disorderly dollar decline. Importantly, MUFG has revised forecasts higher for the dollar relative to earlier expectations, reflecting its resilience despite easing.

Bank of England: Sterling’s Limiting Factor

If the Fed sets the ceiling for GBP/USD, the Bank of England likely defines the floor. After cutting rates five times in 2025, bringing Bank Rate to 4.00%, markets expect further easing. Consensus forecasts see rates falling to 3.25% by Q3 2026, with several institutions calling for 3.00% or lower by year-end.

The rationale is straightforward. UK growth remains weak, GDP contracted in October 2025, and unemployment has risen to 5.0%. At the same time, inflation remains elevated at 3.6%, leaving the BoE balancing fragile growth against incomplete disinflation. Morgan Stanley expects rates as low as 2.75%, a move that would materially erode Sterling’s carry support.

This aggressive easing bias limits Sterling’s ability to outperform, even in a weakening dollar environment. Unlike earlier cycles, GBP’s upside is unlikely to be driven by yield differentials and instead relies on relative economic resilience and capital flows.

Risk Scenarios: What Moves the Needle

Upside risks for GBP/USD are overwhelmingly dollar-centric. A sharper-than-expected US slowdown could force the Fed into faster or deeper cuts, pushing GBP/USD toward the upper end of forecasts. Similarly, a policy misstep that tightens financial conditions into labor market weakness would likely weigh on the dollar.

Sterling-specific upside is harder to justify but not impossible. A stabilization in UK growth, improved productivity trends, or credible fiscal signaling could help GBP outperform expectations, though these remain secondary drivers.

Downside risks remain meaningful. Sticky US inflation could stall Fed easing and preserve dollar yield support. In the UK, fiscal scrutiny is likely to intensify ahead of future budget cycles, particularly if debt dynamics worsen. A global risk-off episode would also favor the dollar, regardless of valuation arguments.

Technical and Positioning Context

From a technical standpoint, GBP/USD faces heavy resistance in the 1.38–1.42 zone, an area that capped rallies in prior cycles. Support near 1.30–1.32 has held consistently, suggesting a broad trading range rather than a trending market.

Positioning remains elevated following Sterling’s 2025 performance, increasing vulnerability to pullbacks if underlying momentum fades. Sustained breaks above 1.38 would likely require either pronounced US weakness or a material improvement in UK fundamentals, neither of which sits in the consensus base case.

Source link

Go to Top